Samuel Kintz
ELVNSamuel Kintz serves as PRESIDENT AND CEO at Enliven Therapeutics, Inc. (ELVN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Samuel Kintz's Insider Trading at Enliven Therapeutics, Inc. (ELVN)
Buys
0 · $0.00
Sells
32 · $7.41M
Total Shares Bought
0
Total Shares Sold
351,305
Related Insiders
Helen Louise Collins
officer: CHIEF MEDICAL OFFICER
ELVNSell · Apr 21, 2026
Benjamin Hohl
officer: CHIEF FINANCIAL OFFICER
ELVNSell · Mar 10, 2026
Richard A. Heyman
Director
ELVNSell · Feb 19, 2026
Joseph P Lyssikatos
officer: CHIEF SCIENTIFIC OFFICER
ELVNSell · Feb 10, 2026
Anish Patel
officer: CHIEF OPERATING OFFICER
ELVNSell · Jan 13, 2026